{"id":80345,"date":"2018-07-03T13:02:14","date_gmt":"2018-07-03T20:02:14","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2018\/07\/can-the-gene-and-cell-therapy-revolution-scale-up"},"modified":"2018-07-03T13:02:14","modified_gmt":"2018-07-03T20:02:14","slug":"can-the-gene-and-cell-therapy-revolution-scale-up","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2018\/07\/can-the-gene-and-cell-therapy-revolution-scale-up","title":{"rendered":"Can the gene and cell therapy revolution scale up?"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/can-the-gene-and-cell-therapy-revolution-scale-up.jpg\"><\/a><\/p>\n<blockquote><p>\u201cI believe gene therapy will become a mainstay in treating, and maybe curing, many of our most devastating and intractable illnesses,\u201d said FDA commissioner Dr Scott Gottlieb after Luxturna\u2019s approval.<\/p><\/blockquote>\n<p>As innovative gene and cell therapies continue to make the transition from the laboratory to the clinic, they are bringing with them the promise of truly personalised medicine. The last few years have seen the regulatory approval of the first gene therapies that take a patient\u2019s own immune cells and genetically engineer them to target cancer cells more effectively.<\/p>\n<p>These chimeric antigen receptor T-cell (CAR-T) therapies now represent a rapidly growing field, with Novartis\u2019s Kymriah, the first CAR-T therapy approved by the US Food and Drug Administration (FDA) in August 2017 for the treatment of a rare blood cancer, seen as the tip of the iceberg for this treatment class\u2019 potential. Approval of Kite Pharma\u2019s Yescarta, a CAR-T treatment for certain forms of non-Hodgkin lymphoma, followed just a few months later.<\/p>\n<p><!-- Link: <a href=\"https:\/\/scienceofsingularity.com\/2018\/05\/31\/can-the-gene-and-cell-therapy-revolution-scale-up\/\">https:\/\/scienceofsingularity.com\/2018\/05\/31\/can-the-gene-and...-scale-up\/<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u201cI believe gene therapy will become a mainstay in treating, and maybe curing, many of our most devastating and intractable illnesses,\u201d said FDA commissioner Dr Scott Gottlieb after Luxturna\u2019s approval. As innovative gene and cell therapies continue to make the transition from the laboratory to the clinic, they are bringing with them the promise of [\u2026]<\/p>\n","protected":false},"author":374,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412],"tags":[],"class_list":["post-80345","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/80345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/374"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=80345"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/80345\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=80345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=80345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=80345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}